Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V de Haas

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Oncogene|July 14, 2015
miR-139-5p controls translation in myeloid leukemia through EIF4G2S Emmrich, F Engeland, M El-Khatib, et al.
Leukemia|November 25, 2010
Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemiaE Waanders, V H J van der Velden, C E van der Schoot, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2019
Population Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Prophylaxis in Pediatric Acute Lymphoblastic Leukemia PatientsS D T Sassen, R A A Mathôt, R Pieters, et al.
Oncogene|September 12, 2017
MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AMLN S D Larmonie, T C J M Arentsen-Peters, A Obulkasim, et al.
Leukemia|February 25, 2014
Unique BHLHB3 overexpression in pediatric acute myeloid leukemia with t(6;11)(q27;q23)E A Coenen, C M Zwaan, J Stary, et al.
Leukemia|August 13, 2011
Low frequency of DNMT3A mutations in pediatric AML, and the identification of the OCI-AML3 cell line as an in vitro modelI H I M Hollink, Q Feng, A A Danen-van Oorschot, et al.
Leukemia|May 4, 2011
Frequency and prognostic implications of JAK 1-3 aberrations in Down syndrome acute lymphoblastic and myeloid leukemiaM Blink, T D Buitenkamp, M M van den Heuvel-Eibrink, et al.
Leukemia|October 4, 2017
RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemiaI S Jerchel, A Q Hoogkamer, I M Ariës, et al.
Leukemia|February 22, 2013
Telomere length and telomerase complex mutations in pediatric acute myeloid leukemiaA M Aalbers, R T Calado, N S Young, et al.
Leukemia|November 26, 2013
miR-9 is a tumor suppressor in pediatric AML with t(8;21)S Emmrich, J E Katsman-Kuipers, K Henke, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Oncogene|July 14, 2015
miR-139-5p controls translation in myeloid leukemia through EIF4G2S Emmrich, F Engeland, M El-Khatib, et al.
Leukemia|November 25, 2010
Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemiaE Waanders, V H J van der Velden, C E van der Schoot, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2019
Population Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Prophylaxis in Pediatric Acute Lymphoblastic Leukemia PatientsS D T Sassen, R A A Mathôt, R Pieters, et al.
Oncogene|September 12, 2017
MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AMLN S D Larmonie, T C J M Arentsen-Peters, A Obulkasim, et al.
Leukemia|February 25, 2014
Unique BHLHB3 overexpression in pediatric acute myeloid leukemia with t(6;11)(q27;q23)E A Coenen, C M Zwaan, J Stary, et al.
Leukemia|August 13, 2011
Low frequency of DNMT3A mutations in pediatric AML, and the identification of the OCI-AML3 cell line as an in vitro modelI H I M Hollink, Q Feng, A A Danen-van Oorschot, et al.
Leukemia|May 4, 2011
Frequency and prognostic implications of JAK 1-3 aberrations in Down syndrome acute lymphoblastic and myeloid leukemiaM Blink, T D Buitenkamp, M M van den Heuvel-Eibrink, et al.
Leukemia|October 4, 2017
RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemiaI S Jerchel, A Q Hoogkamer, I M Ariës, et al.
Leukemia|February 22, 2013
Telomere length and telomerase complex mutations in pediatric acute myeloid leukemiaA M Aalbers, R T Calado, N S Young, et al.
Leukemia|November 26, 2013
miR-9 is a tumor suppressor in pediatric AML with t(8;21)S Emmrich, J E Katsman-Kuipers, K Henke, et al.
Pageof 5